rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2026-39-45rsp-3872Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПсихические расстройства у пациентов с псориатическим артритомMental disorders in patients with psoriatic arthritishttps://orcid.org/0000-0001-6802-0268БорисоваА. Б.BorisovaA. B.

Борисова Анастасия Борисовна

115522, Москва, Каширское шоссе, 34а

Anastasia B. Borisova 

115522, Moscow, Kashirskoye Highway, 34A

desolatorius@yandex.ruhttps://orcid.org/0000-0001-5210-2605ВельтищевД. Ю.VeltishchevD. Yu.

115522, Москва, Каширское шоссе, 34а

117997, Москва, ул. Островитянова, 1

Dmitry Yu. Veltishchev 

115522, Moscow, Kashirskoye Highway, 34A

117997, Moscow, Ostrovitianova str., 1

https://orcid.org/0000-0003-0579-1131КоротаеваТ. В.KorotaevaT. V.

115522, Москва, Каширское шоссе, 34а

Tatiana V. Korotaeva 

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0003-4005-1745ТремаскинаП. О.TremaskinaP. O.

115522, Москва, Каширское шоссе, 34а

Polina O. Tremaskina 

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0001-8626-8419ВоробьеваЛ. Д.VorobyovaL. D.

115522, Москва, Каширское шоссе, 34а

Lyubov D. Vorobyova 

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-1598-8360НасоновЕ. Л.NasonovE. L.

115522, Москва, Каширское шоссе, 34а

Evgeny L. Nasonov

115522, Moscow, Kashirskoye Highway, 34A

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой» ; ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииРоссияV.A. Nasonova Research Institute of Rheumatology ; N.I. Pirogov Russian National Research Medical UniversityRussian Federation2026020320266413945Copyright © Борисова А.Б., Вельтищев Д.Ю., Коротаева Т.В., Тремаскина П.О., Воробьева Л.Д., Насонов Е.Л., 20262026Борисова А.Б., Вельтищев Д.Ю., Коротаева Т.В., Тремаскина П.О., Воробьева Л.Д., Насонов Е.Л.Borisova A.B., Veltishchev D.Y., Korotaeva T.V., Tremaskina P.O., Vorobyova L.D., Nasonov E.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3872

Псориатический артрит – хроническое, прогрессирующее гетерогенное заболевание, включающее периферический артрит и спондилоартрит, связанное с кожным псориазом и поражающее различные системы организма. Помимо влияния на соматическое здоровье, псориатический артрит взаимосвязан с психическими расстройствами. Воспалительные процессы, хроническая боль, другие сопутствующие соматические заболевания во многом способствуют развитию психических расстройств, прежде всего депрессивных и тревожных. Психические расстройства часто предшествуют и сопутствуют псориатическому артриту, негативно влияют на выраженность, течение заболевания, а также на эффективность лечения, способствуя формированию терапевтической резистентности.

Psoriatic arthritis is a chronic, progressive, heterogeneous disease that includes peripheral arthritis and spondyloarthritis, associated with cutaneous psoriasis and affecting various body systems. In addition to its impact on physical health, psoriatic arthritis is interconnected with mental disorders. Inflammatory processes, chronic pain, and other comorbid somatic conditions significantly contribute to the development of mental disorders, primarily depressive and anxiety disorders. Mental disorders often precede and accompany psoriatic arthritis, negatively influencing the severity, disease progression, and treatment efficacy, promoting the development of therapeutic resistance.

псориатический артритпсихические расстройствакогнитивные нарушенияpsoriatic arthritismental disorderscognitive impairmentСтатья подготовлена в рамках фундаментальной научной темы «Эволюция аксиальных спондилоартритов на основе комплексного динамического изучения молекулярно биологических, молекулярно-генетических, клинико-визуализационных факторов прогрессирования заболевания, качества жизни, коморбидности и таргетной инновационной терапии (№РК125020501435-8).ReferencesMathew AJ, Chandran V. Depression in psoriatic arthritis: Dimensional aspects and link with systemic inflammation. Rheumatol Ther. 2020;7(2):287-300. doi: 10.1007/s40744-020-00207-6Mathew AJ, Chandran V. Depression in psoriatic arthritis: Dimensional aspects and link with systemic inflammation. Rheumatol Ther. 2020;7(2):287-300. doi: 10.1007/s40744-020-00207-6Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(6):1481-1488. doi: 10.1016/j.semarthrit.2020.02.001Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(6):1481-1488. doi: 10.1016/j.semarthrit.2020.02.001Goel N, Wallace EB, Lindsay C. Hot topics: Depression in individuals with psoriasis and psoriatic arthritis. J Rheumatol. 2024;51(Suppl 2):43-50. doi: 10.3899/jrheum.2024-0362Goel N, Wallace EB, Lindsay C. Hot topics: Depression in individuals with psoriasis and psoriatic arthritis. J Rheumatol. 2024;51(Suppl 2):43-50. doi: 10.3899/jrheum.2024-0362Корсакова ЮЛ, Коротаева ТВ, Логинова ЕЮ, Губарь ЕЕ, Василенко ЕА, Василенко АА, и др. Распространенность коморбидных и сопутствующих заболеваний при псориатическом артрите по данным Общероссийского регистра больных псориатическим артритом. Научно-практическая ревматология. 2021;59(3):275-281. doi: 10.47360/1995-4484-2021-275-281Korsakova YuL, Korotaeva TV, Loginova EYu, Gubar EE, Vasilenko EA, Vasilenko AA, et al. The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(3):275-281 (In Russ.). doi: 10.47360/1995-4484-2021-275-281Carvalho AF, Machado MO, Mallia E, Liu X, Eder L, Solmi M, et al. The association between schizophrenia spectrum disorders and psoriasis: A large-scale population-based case-control study. Br J Dermatol. 2021;185(2):443-445. doi: 10.1111/bjd.20094Carvalho AF, Machado MO, Mallia E, Liu X, Eder L, Solmi M, et al. The association between schizophrenia spectrum disorders and psoriasis: A large-scale population-based case-control study. Br J Dermatol. 2021;185(2):443-445. doi: 10.1111/bjd.20094Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217-225. doi: 10.1007/s10067-019-04734-8Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217-225. doi: 10.1007/s10067-019-04734-8Lada G, Chinoy H, Heal C, Warren RB, Talbot PS, Kleyn CE. Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis: A cross-sectional study in a tertiary setting. J Acad Consult Liaison Psychiatry. 2022;63(4):372-383. doi: 10.1016/j.jaclp.2021.12.007Lada G, Chinoy H, Heal C, Warren RB, Talbot PS, Kleyn CE. Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis: A cross-sectional study in a tertiary setting. J Acad Consult Liaison Psychiatry. 2022;63(4):372-383. doi: 10.1016/j.jaclp.2021.12.007Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017;56(6): 907-911. doi: 10.1093/rheumatology/kew502Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017;56(6): 907-911. doi: 10.1093/rheumatology/kew502Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31(7):1168-1175. doi: 10.1111/jdv.14175Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31(7):1168-1175. doi: 10.1111/jdv.14175Wang Y, Wang X, Gu X, Pan J, Ouyang Z, Lin W, et al. Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals. J Affect Disord. 2023;337:27-36. doi: 10.1016/j.jad.2023.05.059Wang Y, Wang X, Gu X, Pan J, Ouyang Z, Lin W, et al. Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals. J Affect Disord. 2023;337:27-36. doi: 10.1016/j.jad.2023.05.059Lewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG, et al. Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: A population-based study. J Invest Dermatol. 2017;137(4):828- 835. doi: 10.1016/j.jid.2016.11.032Lewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG, et al. Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: A population-based study. J Invest Dermatol. 2017;137(4):828- 835. doi: 10.1016/j.jid.2016.11.032Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE. Associations between psoriatic arthritis and mental health among patients with psoriasis: A replication and extension study using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Skin Health Dis. 2022;2(4):e149. doi: 10.1002/ski2.149Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE. Associations between psoriatic arthritis and mental health among patients with psoriasis: A replication and extension study using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Skin Health Dis. 2022;2(4):e149. doi: 10.1002/ski2.149Lai TL, Au CK, Chung HY, Lau CS. Depression in psoriatic arthritis: Related to socio-demographics, comorbid loads or disease activity? Int J Rheum Dis. 2022;25(4):474-480. doi: 10.1111/1756-185X.14298Lai TL, Au CK, Chung HY, Lau CS. Depression in psoriatic arthritis: Related to socio-demographics, comorbid loads or disease activity? Int J Rheum Dis. 2022;25(4):474-480. doi: 10.1111/1756-185X.14298Tabra SA, abd Elghany SE, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: Relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022;41(11):3391-3399. doi: 10.1007/s10067-022-06300-1Tabra SA, abd Elghany SE, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: Relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022;41(11):3391-3399. doi: 10.1007/s10067-022-06300-1Филимонова ОГ, Симонова ОВ. Качество жизни и психоэмоциональный статус больных псориатическим артритом. Научно-практическая ревматология. 2009;47(3):25-28.Filimonova OG, Simonova OV. Quality of life and psycho-emotional status of patients with psoriatic arthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2009;47(3):25-28 (In Russ.).Лисицына ТА, Вельтищев ДЮ, Насонов ЕЛ, Лила АМ. Психиатрические аспекты спондилоартритов. Научно-практическая ревматология. 2020;58(6):716-724. doi: 10.47360/1995-4484-2020-716-724Lisitsyna TA, Veltishchev DYu, Nasonov EL, Lila AM. Psychiatric aspects of spondyloarthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(6):716-724 (In Russ.). doi: 10.47360/1995-4484-2020-716-724Zafiriou E, Daponte AI, Siokas V, Tsigalou C, Dardiotis E, Bogdanos DP. Depression and obesity in patients with psoriasis and psoriatic arthritis: Is IL-17-mediated immune dysregulation the connecting link? Front Immunol. 2021;12:699848. doi: 10.3389/fimmu.2021.699848Zafiriou E, Daponte AI, Siokas V, Tsigalou C, Dardiotis E, Bogdanos DP. Depression and obesity in patients with psoriasis and psoriatic arthritis: Is IL-17-mediated immune dysregulation the connecting link? Front Immunol. 2021;12:699848. doi: 10.3389/fimmu.2021.699848De Lorenzis E, Natalello G, Bruno D, Tanti G, Magurano MR, Lucchetti D, et al. Psoriatic arthritis and depressive symptoms: Does systemic inflammation play a role? Clin Rheumatol. 2021;40(5):1893-1902. doi: 10.1007/s10067-020-05417-5De Lorenzis E, Natalello G, Bruno D, Tanti G, Magurano MR, Lucchetti D, et al. Psoriatic arthritis and depressive symptoms: Does systemic inflammation play a role? Clin Rheumatol. 2021;40(5):1893-1902. doi: 10.1007/s10067-020-05417-5Wang X, Wu L, Liu J, Ma C, Liu J, Zhang Q. The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions. Biomed Pharmacother. 2025;182:117802. doi: 10.1016/j.biopha.2024.117802Wang X, Wu L, Liu J, Ma C, Liu J, Zhang Q. The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions. Biomed Pharmacother. 2025;182:117802. doi: 10.1016/j.biopha.2024.117802Waszczak-Jeka M, Żuchowski P, Dura M, Bielewicz-Zielińska A, Kułakowski M, Góralczyk A. Interleukin levels and depressive symptoms in psoriatic arthritis patients: Insights from a case-control study on socio-demographic factors and disease perception. Rheumatol Int. 2024;44(7):1337-1343. doi: 10.1007/s00296-024-05599-0Waszczak-Jeka M, Żuchowski P, Dura M, Bielewicz-Zielińska A, Kułakowski M, Góralczyk A. Interleukin levels and depressive symptoms in psoriatic arthritis patients: Insights from a case-control study on socio-demographic factors and disease perception. Rheumatol Int. 2024;44(7):1337-1343. doi: 10.1007/s00296-024-05599-0Лисицына ТА, Вельтищев ДЮ, Краснов ВН, Насонов ЕЛ. Клинико-патогенетические взаимосвязи иммуновоспалительных ревматических заболеваний и психических расстройств. Клиническая медицина. 2014;(1):12-20.Lisitsina TA, Veltishchev DYu, Krasnov VN, Nasonov EL. Clinical and pathogenetic relationships between immuno-inflammatory rheumatic diseases and psychic disorders. Clinical Medicine. 2014;(1):12-20 (In Russ.).Chaudhary R, Prasad A, Agarwal V, Rehman M, Kumar A, Kaushik AS, et al. Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol. 2023;125(Pt A):111046. doi: 10.1016/j.intimp.2023.111046Chaudhary R, Prasad A, Agarwal V, Rehman M, Kumar A, Kaushik AS, et al. Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol. 2023;125(Pt A):111046. doi: 10.1016/j.intimp.2023.111046Алексеева СА. Предрасполагающая роль детских психических травм при иммуновоспалительных ревматических заболеваниях и психических расстройствах. Научно-практическая ревматология. 2022;60(4):438-444. doi: 10.47360/1995-4484-2022-438-444Alekseeva SA. Predisposing role of childhood mental trauma in immunoinflammatory rheumatic diseases and mental disorders. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2022;60(4):438- 444 (In Russ.). doi: 10.47360/1995-4484-2022-438-444McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, et al. Depression and anxiety in psoriatic disease: Prevalence and associated factors. J Rheumatol. 2014;41(5):887-896. doi: 10.3899/jrheum.130797McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, et al. Depression and anxiety in psoriatic disease: Prevalence and associated factors. J Rheumatol. 2014;41(5):887-896. doi: 10.3899/jrheum.130797Salihoglu S, Dogan SC, Kavakci O. Effects of childhood psychological trauma on rheumatic diseases. Eur J Rheumatol. 2019;6(3):126-129. doi: 10.5152/eurjrheum.2019.18184Salihoglu S, Dogan SC, Kavakci O. Effects of childhood psychological trauma on rheumatic diseases. Eur J Rheumatol. 2019;6(3):126-129. doi: 10.5152/eurjrheum.2019.18184Sun Y, Li Y, Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022;12(1):20526. doi: 10.1038/s41598-022-24872-5Sun Y, Li Y, Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022;12(1):20526. doi: 10.1038/s41598-022-24872-5Freuer D, Linseisen J, Meisinger C. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis. JAMA Dermatol. 2022;158(11):1262-1268. doi: 10.1001/jamadermatol.2022.3682Freuer D, Linseisen J, Meisinger C. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis. JAMA Dermatol. 2022;158(11):1262-1268. doi: 10.1001/jamadermatol.2022.3682Weijers JM, Müskens WD, Van Riel PLCM. Effect of significant weight loss on disease activity: Reason to implement this nonpharmaceutical intervention in daily clinical practice. RMD Open. 2021;7(1):e001498. doi: 10.1136/rmdopen-2020-001498Weijers JM, Müskens WD, Van Riel PLCM. Effect of significant weight loss on disease activity: Reason to implement this nonpharmaceutical intervention in daily clinical practice. RMD Open. 2021;7(1):e001498. doi: 10.1136/rmdopen-2020-001498Ishchenko A, Pazmino S, Neerinckx B, Lories R, de Vlam K. Comorbidities in early psoriatic arthritis: Data from the metabolic disturbances in psoriatic arthritis cohort study. Arthritis Care Res (Hoboken). 2024;76(2):231-240. doi: 10.1002/acr.25230Ishchenko A, Pazmino S, Neerinckx B, Lories R, de Vlam K. Comorbidities in early psoriatic arthritis: Data from the metabolic disturbances in psoriatic arthritis cohort study. Arthritis Care Res (Hoboken). 2024;76(2):231-240. doi: 10.1002/acr.25230Moroni L, Farina N, Dagna L. Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol. 2020;39(4):1039-1047. doi: 10.1007/s10067-020-04963-2Moroni L, Farina N, Dagna L. Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol. 2020;39(4):1039-1047. doi: 10.1007/s10067-020-04963-2Valero-Jaimes JA, López-González R, Martín-Martínez MA, García-Gómez C, Sánchez-Alonso F, Sánchez-Costa JT, et al. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the Cardiovascular in Rheumatology (Carma) project. J Clin Med. 2021;10(3):382. doi: 10.3390/jcm10030382Valero-Jaimes JA, López-González R, Martín-Martínez MA, García-Gómez C, Sánchez-Alonso F, Sánchez-Costa JT, et al. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the Cardiovascular in Rheumatology (Carma) project. J Clin Med. 2021;10(3):382. doi: 10.3390/jcm10030382Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, et al. Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: A clinical cohort study. Rheumatology (Oxford). 2021;60(7):3289-3300. doi: 10.1093/rheumatology/keaa780Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, et al. Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: A clinical cohort study. Rheumatology (Oxford). 2021;60(7):3289-3300. doi: 10.1093/rheumatology/keaa780Moradi Y, Albatineh AN, Mahmoodi H, Gheshlagh RG. The relationship between depression and risk of metabolic syndrome: A meta-analysis of observational studies. Clin Diabetes Endocrinol. 2021;7(1):4. doi: 10.1186/s40842-021-00117-8Moradi Y, Albatineh AN, Mahmoodi H, Gheshlagh RG. The relationship between depression and risk of metabolic syndrome: A meta-analysis of observational studies. Clin Diabetes Endocrinol. 2021;7(1):4. doi: 10.1186/s40842-021-00117-8Al-Khatib Y, Akhtar MA, Kanawati MA, Mucheke R, Mahfouz M, Al-Nufoury M. Depression and metabolic syndrome: A narrative review. Cureus. 2022;14(2):e22153. doi: 10.7759/cureus.22153Al-Khatib Y, Akhtar MA, Kanawati MA, Mucheke R, Mahfouz M, Al-Nufoury M. Depression and metabolic syndrome: A narrative review. Cureus. 2022;14(2):e22153. doi: 10.7759/cureus.22153Lamers F, Milaneschi Y, Vinkers CH, Schoevers RA, Giltay EJ, Penninx BWJH. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav Immun. 2020;88:174-183. doi: 10.1016/j.bbi.2020.04.002Lamers F, Milaneschi Y, Vinkers CH, Schoevers RA, Giltay EJ, Penninx BWJH. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav Immun. 2020;88:174-183. doi: 10.1016/j.bbi.2020.04.002Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: A bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11(1):633. doi: 10.1038/s41398-021-01759-zZhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: A bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11(1):633. doi: 10.1038/s41398-021-01759-zKhanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic low-grade inflammation and its markers. Cureus. 2022;14(2):e22711. doi: 10.7759/cureus.22711Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic low-grade inflammation and its markers. Cureus. 2022;14(2):e22711. doi: 10.7759/cureus.22711Carvalho LM, Carvalho BG, Souza LL, da Mota JC, Ribeiro AA, Nicoletti CF. Obesity as an aggravating factor of systemic lupus erythematosus disease: What we already know and what we must explore. A rapid scoping review. Nutrition. 2024;128:112559. doi: 10.1016/j.nut.2024.112559Carvalho LM, Carvalho BG, Souza LL, da Mota JC, Ribeiro AA, Nicoletti CF. Obesity as an aggravating factor of systemic lupus erythematosus disease: What we already know and what we must explore. A rapid scoping review. Nutrition. 2024;128:112559. doi: 10.1016/j.nut.2024.112559Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, SánchezMargalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21(16):5887. doi: 10.3390/ijms21165887Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, SánchezMargalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21(16):5887. doi: 10.3390/ijms21165887Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front Physiol. 2020;11:578966. doi: 10.3389/fphys.2020.578966Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front Physiol. 2020;11:578966. doi: 10.3389/fphys.2020.578966Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis. 2019;22(6):967-973. doi: 10.1111/1756-185X.13553Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis. 2019;22(6):967-973. doi: 10.1111/1756-185X.13553Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31-41. doi: 10.1001/2013.jamapsychiatry.4Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31-41. doi: 10.1001/2013.jamapsychiatry.4Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: A meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016;21(5):642-649. doi: 10.1038/mp.2015.67Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: A meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016;21(5):642-649. doi: 10.1038/mp.2015.67Sood A, Raji MA. Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying antirheumatic drugs. Clin Rheumatol. 2021;40(4):1221-1231. doi: 10.1007/s10067-020-05372-1Sood A, Raji MA. Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying antirheumatic drugs. Clin Rheumatol. 2021;40(4):1221-1231. doi: 10.1007/s10067-020-05372-1Schiweck C, Aichholzer M, Reif A, Edwin Thanarajah S. Targeting IL-17A signaling in suicidality, promise or the long arm of coincidence? Evidence in psychiatric populations revisited. J Affect Disord Rep. 2023;11:100454. doi: 10.1016/j.jadr.2022.100454Schiweck C, Aichholzer M, Reif A, Edwin Thanarajah S. Targeting IL-17A signaling in suicidality, promise or the long arm of coincidence? Evidence in psychiatric populations revisited. J Affect Disord Rep. 2023;11:100454. doi: 10.1016/j.jadr.2022.100454Каратеев АЕ, Полищук ЕЮ, Дубинина ТВ. Интерлейкин 17 как центральный компонент патогенеза боли, связанной с иммуновоспалительным процессом: новая «мишень» фармакотерапии. Научно-практическая ревматология. 2024;62(2):154-161. doi: 10.47360/1995-4484-2024-154-161Karateev АЕ, Polishchuk ЕYu, Dubinina ТV. Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2024;62(2):154-161 (In Russ.). doi: 10.47360/1995-4484-2024-154-161Gialouri CG, Evangelatos G, Zhao SS, Kouna K, Karamanakos A, Iliopoulos A, et al. Depression and anxiety in a real-world psoriatic arthritis longitudinal study: Should we focus more on patients’ perception? Clin Exp Rheumatol. 2023;41(1):159-165. doi: 10.55563/clinexprheumatol/8qxo80Gialouri CG, Evangelatos G, Zhao SS, Kouna K, Karamanakos A, Iliopoulos A, et al. Depression and anxiety in a real-world psoriatic arthritis longitudinal study: Should we focus more on patients’ perception? Clin Exp Rheumatol. 2023;41(1):159-165. doi: 10.55563/clinexprheumatol/8qxo80Акулинушкина ЕЮ, Якупова СП, Якупов ЭЗ, Иванова ЛВ, Брагина ТА, Максимов НИ. Центральная сенситизация при псориатическом артрите. Вестник современной клинической медицины. 2023;16:16-21. doi: 10.20969/VSKM.2023.16(5).16-21Akulinushkina EYu, Yakupova SP, Yakupov EZ, Ivanova LV, Bragina TA, Maksimov NI. Central sensitization in psoriatic arthritis. Bulletin of Contemporary Clinical Medicine. 2023;16:16-21 (In Russ.). doi: 10.20969/VSKM.2023.16(5).16-21Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary mania induced by TNF-α inhibitors: A systematic review. Psychiatry Clin Neurosci. 2022;76(1):15-21. doi: 10.1111/pcn.13302Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary mania induced by TNF-α inhibitors: A systematic review. Psychiatry Clin Neurosci. 2022;76(1):15-21. doi: 10.1111/pcn.13302Lada G. Immune links in comorbid depression and psoriasis: A narrative mini-review and perspective. Brain Behav Immun Health. 2025;44:100949. doi: 10.1016/j.bbih.2025.100949Lada G. Immune links in comorbid depression and psoriasis: A narrative mini-review and perspective. Brain Behav Immun Health. 2025;44:100949. doi: 10.1016/j.bbih.2025.100949Ribeiro AL, Singla S, Chandran V, Chronis N, Liao W, Lindsay C, et al. Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): A GRAPPA perspective from an international survey of healthcare professionals. Rheumatol Adv Pract. 2024;8(3):rkae074. doi: 10.1093/rap/rkae074Ribeiro AL, Singla S, Chandran V, Chronis N, Liao W, Lindsay C, et al. Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): A GRAPPA perspective from an international survey of healthcare professionals. Rheumatol Adv Pract. 2024;8(3):rkae074. doi: 10.1093/rap/rkae074Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430-1434. doi: 10.1002/acr.24593Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430-1434. doi: 10.1002/acr.24593Martins A, Oliveira D, Nicolau R, Rocha TM, Bernardo A, Costa L, et al. What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs? Clin Rheumatol. 2024;43(1):251-258. doi: 10.1007/s10067-023-06806-2Martins A, Oliveira D, Nicolau R, Rocha TM, Bernardo A, Costa L, et al. What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs? Clin Rheumatol. 2024;43(1):251-258. doi: 10.1007/s10067-023-06806-2Haugeberg G, Hoff M, Kavanaugh A, Michelsen B. Psoriatic arthritis: Exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates. Arthritis Res Ther. 2020;22(1):198. doi: 10.1186/s13075-020-02294-wHaugeberg G, Hoff M, Kavanaugh A, Michelsen B. Psoriatic arthritis: Exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates. Arthritis Res Ther. 2020;22(1):198. doi: 10.1186/s13075-020-02294-wBell KA, Balogh EA, Feldman SR. An update on the impact of depression on the treatment of psoriasis. Expert Opin Pharmacother. 2021;22(6):695-703. doi: 10.1080/14656566.2020.1849141Bell KA, Balogh EA, Feldman SR. An update on the impact of depression on the treatment of psoriasis. Expert Opin Pharmacother. 2021;22(6):695-703. doi: 10.1080/14656566.2020.1849141Türk İ, Aşık MA, Acemoğlu ŞŞZ, Varkal G, Ünal İ. Fibromyalgia and associated factors in patients with axial spondyloarthritis: The effect of fibromyalgia on disease activity. Revista Colombiana de Reumatologia. 2024;31(2):159-165. doi: 10.1016/j.rcreu.2022.10.001Türk İ, Aşık MA, Acemoğlu ŞŞZ, Varkal G, Ünal İ. Fibromyalgia and associated factors in patients with axial spondyloarthritis: The effect of fibromyalgia on disease activity. Revista Colombiana de Reumatologia. 2024;31(2):159-165. doi: 10.1016/j.rcreu.2022.10.001Toledano E, Hidalgo C, Gómez-Lechón L, Ibáñez M, Chacón CC, Martín-Vallejo J, et al. SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: A cross-sectional study. Sci Rep. 2023;13(1): 22927. doi: 10.1038/s41598-023-48723-zToledano E, Hidalgo C, Gómez-Lechón L, Ibáñez M, Chacón CC, Martín-Vallejo J, et al. SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: A cross-sectional study. Sci Rep. 2023;13(1): 22927. doi: 10.1038/s41598-023-48723-zKetenci S, Uzuner B, Bilgici A. Comparison of quality of life, depression and fatigue in patients with psoriasis and psoriatic arthritis. J Experim Clin Med (Turkey). 2022;39(1):174-179. doi: 10.52142/omujecm.39.1.35Ketenci S, Uzuner B, Bilgici A. Comparison of quality of life, depression and fatigue in patients with psoriasis and psoriatic arthritis. J Experim Clin Med (Turkey). 2022;39(1):174-179. doi: 10.52142/omujecm.39.1.35Nymand L, Kristensen LE, Thomsen SF, Thyssen JP, Egeberg A. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study. J Am Acad Dermatol. 2024;91(1):57-63. doi: 10.1016/j.jaad.2024.02.026Nymand L, Kristensen LE, Thomsen SF, Thyssen JP, Egeberg A. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study. J Am Acad Dermatol. 2024;91(1):57-63. doi: 10.1016/j.jaad.2024.02.026Cajamarca-Barón J, Guavita-Navarro D, Gallego-Cardona L, Buitrago-Bohórquez J, Guevara D, Rivadeneira S, et al. Mood disorders in psoriatic arthritis. Revista Colombiana de Reumatología. 2023;30:S97-S104. doi: 10.1016/J.RCREU.2023.02.013Cajamarca-Barón J, Guavita-Navarro D, Gallego-Cardona L, Buitrago-Bohórquez J, Guevara D, Rivadeneira S, et al. Mood disorders in psoriatic arthritis. Revista Colombiana de Reumatología. 2023;30:S97-S104. doi: 10.1016/J.RCREU.2023.02.013Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, et al. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int. 2023;43(1):89-97. doi: 10.1007/s00296-022-05248-4Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, et al. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int. 2023;43(1):89-97. doi: 10.1007/s00296-022-05248-4Garcia LOKL, Júnior ATS, Gómez DCDS, Yoshikawa GSS, Kamikoga CK, Vitturi BK. Cognitive impairment in patients with psoriatic arthritis. Acta Neurol Belg. 2022;122(1):91-96. doi: 10.1007/s13760-021-01644-yGarcia LOKL, Júnior ATS, Gómez DCDS, Yoshikawa GSS, Kamikoga CK, Vitturi BK. Cognitive impairment in patients with psoriatic arthritis. Acta Neurol Belg. 2022;122(1):91-96. doi: 10.1007/s13760-021-01644-yDi Carlo M, Becciolini A, Incorvaia A, Beci G, Smerilli G, Biggioggero M, et al. Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors. Medicine (Baltimore). 2021;100(11):e24833. doi: 10.1097/MD.0000000000024833Di Carlo M, Becciolini A, Incorvaia A, Beci G, Smerilli G, Biggioggero M, et al. Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors. Medicine (Baltimore). 2021;100(11):e24833. doi: 10.1097/MD.0000000000024833Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: A systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36-43.Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: A systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36-43.

The authors declare that there are no conflicts of interest present.